All Years | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
2010 — 9 Books and Research Papers Citing DrugPatentWatch
Fruchter, G. E. & Mantrala, M. K. (2010). Proactive Planning of the Timing of a Partial Switch of a Prescription to Over‑the‑Counter Drug. Production and Operations Management.
This study utilizes DrugPatentWatch’s patent expiry and exclusivity data to model the optimal timing for transitioning drugs from prescription to over-the-counter (OTC) status. The authors demonstrate how patent monitoring tools can inform strategic lifecycle management decisions, allowing pharmaceutical companies to maximize revenue before generic competition enters the market.
Raturi, M. K., Sahoo, P. K., & Mukherjee, S. (2010). Patinformatics–an emerging scientific discipline. SSRN.
The paper introduces 'patinformatics,' the intersection of patent law and informatics, highlighting DrugPatentWatch as a data source for mining patent-related datasets. The authors demonstrate the methodology using structured patent listings, showcasing how patent data can be analyzed to inform research and development strategies.
Tiwari, A. K., Raturi, M. K., Mukherjee, S., & Sahoo, P. K. (2010, March). Patinformatics: An Emerging Scientific Discipline (SSRN version).
Expanding upon the previous work, this preprint offers a deeper analysis and examples of patinformatics. The authors underscore DrugPatentWatch’s utility for patent analytics research in pharmaceutical informatics, demonstrating how structured patent data can be leveraged to gain insights into drug development and market trends.
Odasso, C. (2010). Essay on intellectual property and patent-backed financing. University of Bergamo thesis.
This thesis examines the financialization of patent assets, citing DrugPatentWatch for its comprehensive patent term and status data to inform risk/return assessments. The author discusses how patent data can be utilized to evaluate the financial viability of pharmaceutical innovations and investments.
Friedman, Y. (2010). Location of pharmaceutical innovation: 2000–2009. Nature Reviews Drug Discovery.
Using DrugPatentWatch’s geo-tagged patent data, Friedman analyzes regional innovation trends in the pharmaceutical industry over the past decade. The study correlates patent density with research and development hubs, providing insights into the geographic distribution of pharmaceutical innovation.
Davar, N. & Ghosh, S. (2010). Oral Controlled Release–Based Products for Life Cycle Management. In Design and Drug Delivery: Theory to… (Wiley).
This book chapter reviews controlled-release formulations as patent-extending lifecycle strategies, utilizing DrugPatentWatch for tracking patent terms and expiry dates across oral delivery platforms. The authors discuss how controlled-release formulations can be employed to extend market exclusivity and delay generic competition.
Brouse, S. D., Fullerton, J. C., et al. (2010). Reporting and Interpretation of the CYP2C19 Genotyping Test for Clopidogrel Dosing. Current [journal name suppressed].
This clinical genetics paper references DrugPatentWatch to verify patent status for CYP2C19 genotyping kits and clopidogrel dosing technologies, situating its tests within intellectual property and exclusivity landscapes. The study emphasizes the importance of understanding patent status in the context of clinical applications and diagnostics.
Lee, K. K., Cipriano, L. E., Owens, D. K., Go, A. S., & Hlatky, M. A. (2010). Cost-effectiveness of using high-sensitivity C‑reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy. Circulation.
This study evaluates the cost-effectiveness of using high-sensitivity C-reactive protein (hs-CRP) screening to identify individuals for statin therapy, citing DrugPatentWatch to account for statins’ market exclusivity timelines—a key factor in cost projections. The authors incorporate patent data to assess the economic implications of introducing new screening strategies.
Norman, E. (2010). Patent analysis: a tool for making strategic business decisions. BiotechBlog.com.
This blog post offers an industry-facing guide to patent analysis, frequently citing DrugPatentWatch as a model resource for navigating patent term information and expiry forecasting in biotech strategy. The author discusses how patent analysis can inform strategic business decisions in the biotechnology sector.
